Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, L.
Right arrow Articles by Parekh, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, L.
Right arrow Articles by Parekh, D.

Clinical Cancer Research, Vol 4, Issue 3 731-741, Copyright © 1998 by American Association for Cancer Research


ARTICLES

Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene

L Yang, R Hwang, Y Chiang, EM Gordon, WF Anderson and D Parekh
Gene Therapy Laboratories, Los Angeles, California, USA.

Transfer of the herpes simplex thymidine kinase (HSV-TK) gene into tumor cells confers sensitivity to the cells to the viral drug ganciclovir (GCV). Although the efficacy of the HSV-TK/GCV approach is well studied, the mechanisms for the resistance of HSV-TK-transduced tumor cells to GCV are poorly understood. Here, we examined the mechanisms for GCV resistance in HSV-TK-transduced gastrointestinal (GI) cell lines. Our results show that GCV sensitivities vary in vitro and in vivo among the different HSV-TK-transduced GI tumor cell lines. GCV-resistant colonies were isolated from several different HSV-TK-transduced GI tumor cell lines after 14 days of GCV treatment. Characterization of GCV-resistant colonies demonstrated that the HSV-TK gene was either partially or completely deleted from the resistant HSV-TK-transduced cells. In the HT-29 RM and MIAPACA-2 RM cells, a 220-bp deletion of the gene was found, whereas in the HT-29 R1-R5-resistant cells, the whole TK gene was found to be absent. Immunocytochemical studies using a polyclonal antibody to the TK protein demonstrated that the HSV-TK protein was absent in the GCV-resistant, HSV-TK-transduced cells. Transfection of the resistant cells with an adenoviral vector containing a HSV-TK gene restored sensitivity to GCV. The presence of GCV-resistant cells was only demonstrable in GI tumor cell lines that also demonstrated a poor bystander effect. Our results suggest that GCV resistance found in tumor cells transduced with a retroviral HSV-TK gene is due to the lack of a functional TK protein in the tumor cells rather than any intrinsic resistance of the cells to GCV. In tumor cells with a good bystander effect, the small percentage of TK-transduced cells that do not express the TK protein are probably killed by the bystander effect because GCV-resistant tumor cells were not found in these cell lines. GCV-resistant tumor cells were found only in tumor cell lines with a poor bystander effect, by which, presumably, the transduced tumor cells lacking a functional TK gene were not killed by the bystander killing effect.


This article has been cited by other articles:


Home page
JNMHome page
M. M. Alauddin, A. Shahinian, R. Park, M. Tohme, J. D. Fissekis, and P. S. Conti
Synthesis and Evaluation of 2'-Deoxy-2'-18F-Fluoro-5-Fluoro-1-{beta}-D-Arabinofuranosyluracil as a Potential PET Imaging Agent for Suicide Gene Expression
J. Nucl. Med., December 1, 2004; 45(12): 2063 - 2069.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Adachi, J. Sampath, L.-b. Lan, D. Sun, P. Hargrove, R. Flatley, A. Tatum, M. Z. Edwards, M. Wezeman, L. Matherly, et al.
Expression of MRP4 Confers Resistance to Ganciclovir and Compromises Bystander Cell Killing
J. Biol. Chem., October 4, 2002; 277(41): 38998 - 39004.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Kurdow, A. S. Boehle, S. Haye, L. Boenicke, B. Schniewind, P. Dohrmann, and H. Kalthoff
Ganciclovir prodrug therapy is effective in a murine xenotransplant model of human lung cancer
Ann. Thorac. Surg., March 1, 2002; 73(3): 905 - 910.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. M. Alauddin, A. Shahinian, E. M. Gordon, J. R. Bading, and P. S. Conti
Preclinical Evaluation of the Penciclovir Analog 9-(4-[18F]Fluoro-3-Hydroxymethylbutyl)Guanine for In Vivo Measurement of Suicide Gene Expression with PET
J. Nucl. Med., November 1, 2001; 42(11): 1682 - 1690.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. T. Tomicic, R. Thust, R. W. Sobol, and B. Kaina
DNA Polymerase {beta} Mediates Protection of Mammalian Cells against Ganciclovir-induced Cytotoxicity and DNA Breakage
Cancer Res., October 1, 2001; 61(20): 7399 - 7403.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. I. Garin, E. Garrett, P. Tiberghien, J. F. Apperley, D. Chalmers, J. V. Melo, and C. Ferrand
Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene
Blood, January 1, 2001; 97(1): 122 - 129.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Galipeau, H. Li, A. Paquin, F. Sicilia, G. Karpati, and J. Nalbantoglu
Vesicular Stomatitis Virus G Pseudotyped Retrovector Mediates Effective in Vivo Suicide Gene Delivery in Experimental Brain Cancer
Cancer Res., May 1, 1999; 59(10): 2384 - 2394.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.